Taro – Recall of clobetasol ointment
December 30, 2021 - The FDA announced a consumer level recall of one lot of Taro’s clobetasol propionate 0.05% ointment due to the presence of Ralstonia pickettii (R. pickettii) bacteria, which was discovered by the manufacturer through routine testing.
Download PDF
